Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0882420100780040503
Korean Journal of Medicine
2010 Volume.78 No. 4 p.503 ~ p.506
A case of thyrotoxicosis after sunitinib treatment
Lee Ho-Young

Kim Mi-Kyung
Kim Nam-Keong
Kim Hye-Sun
Ryu Seong-Yeol
Kwon Ki-Young
Park Keun-Gyu
Abstract
Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by destructive thyroiditis after sunitinib treatment is very rare. Here, we report a patient with overt thyrotoxicosis related to sunitinib therapy.
KEYWORD
Sunitinib, Thyrotoxicosis
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø